Humanin: What It Is and Its U.S. Regulatory Status

What is humanin?

Humanin is a short peptide that is encoded in mitochondrial DNA, the small set of genes found inside mitochondria. It belongs to a group called mitochondrial-derived peptides, which also includes MOTS-c.

Humanin was first described in 2001 by researchers studying brain tissue from people with Alzheimer’s disease. Since then, it has been examined in laboratory and animal research on cell stress and aging. Research in people is limited.

U.S. regulatory status

Current status: Not FDA-approved.

In practical terms, humanin has not gone through the FDA review that a drug must pass before it can be marketed for use in people. There is no FDA-approved product that contains it.

Humanin and its synthetic variants remain research compounds, not medicines.

Why Peptide Labs does not sell humanin

Peptide Labs does not sell this compound. This page is general information, not medical advice. Our Peptide Guide exists to explain what these compounds are and how they are regulated, not to supply them.

Anyone with questions about humanin should speak with a licensed healthcare provider, who can explain the current evidence and the legal status in plain terms.

Related reading

See the full list of compound profiles in the Peptide Guide.